alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 60, Number 59 (Tuesday, March 28, 1995)]
[Notices]
[Page 15933]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-7579]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Institute for 
Occupational Safety and Health; Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following committee meeting.

    Name: Board of Scientific Counselors, National Institute for 
Occupational Safety and Health (BSC, NIOSH).
    Time and Date: 10 a.m.-5 p.m., April 12, 1995.
    Place: The Washington Court Hotel, Ash Room, 525 New Jersey 
Avenue, NW, Washington, DC 20001
    Status: Closed 10 a.m.-12 noon; Open 1 p.m.-5 p.m.
    Purpose: The Board reviews research activities to provide 
guidance on the quality, timeliness, and efficacy of the Institute's 
programs.

    Matters To Be Discussed: The agenda will include personnel and 
organizational issues relating to the reorganization of NIOSH. The 
meeting will convene in closed session from 10 a.m. to 12 noon to 
discuss subject matter relating solely to the internal personnel 
rules and practices of NIOSH. This portion of the meeting will be 
closed to the public in accordance with the provisions set forth in 
section 552b(c)(2), title 5 U.S.C., and the Determination of the 
Associate Director for Management and Operations, CDC, pursuant to 
Pub. L. 92-463. The open portion of the meeting will include a 
report from the Director of NIOSH, a toxicology report, an 
extramural report, and future activities of the Board.

    Agenda items are subject to change as priorities dictate.

    Contact Person for More Information: Richard A. Lemen, Ph.D., 
Executive Secretary, BSC, NIOSH, and Deputy Director, NIOSH, CDC, 
1600 Clifton Road NE., Mailstop D-35, Atlanta, Georgia 30333, 
telephone 404/639-3773.

    Dated: March 22, 1995.
Jack Jackson,
Associate Director for Management and Operations, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 95-7579 Filed 3-27-95; 8:45 am]
BILLING CODE 4163-19-M
DISTRICT COURT OF APPEAL OF FLORIDA

SECOND DISTRICT

JACEK KOZMINSKI and 

BARBARA KOZMINSKI,

Appellants,

v.

CHRISTIAN B. KOEPPEN, deceased, and 

EDITH E. KOEPPEN, as trustees on behalf of the 

Christian B. Koeppen and Edith E. Koeppen Revocable 

Trust dated April 5, 2016; JOY BROWN; and BRAD BROWN,

Appellees.

No. 2D23-1575

March 8, 2024

Appeal from the Circuit Court for Pinellas County; Thomas M. 

Ramsberger, Judge.

Cristen Heather Martinez of Martinez Law, P.A., Lutz, for Appellants.

Cary A. Cash of Freeman, Goldis & Cash, P.A., St. Petersburg, for 

Appellee Christian B. Koeppen, deceased, and Edith E. Koeppen, as 

trustees on behalf of the Christian B. Koeppen and Edith E. Koeppen 

Revocable Trust dated April 5, 2016.

No appearance for the remaining Appellees.

MORRIS, Judge.

Jacek and Barbara Kozminski appeal from a final order granting 

specific performance of a contract for the sale of residential real property 
2

and requiring them to sell the subject property to Christian B. and Edith 

E. Koeppen, as trustees on behalf of the Christian B. Koeppen and Edith 

E. Koeppen Revocable Trust, dated April 5, 2016. We need not address 

all of the issues raised by the Kozminskis as appellee Edith E. Koeppen 

has properly conceded error.1 Pursuant to Parkland Condominium Ass'n 

v. Henderson, 350 So. 3d 484, 486 (Fla. 2d DCA 2022), the mediated 

settlement agreement in this case was not enforceable because the 

Kozminskis did not sign it.2 We therefore reverse the final order and 

remand for further proceedings. 

Reversed and remanded. 

SILBERMAN and ROTHSTEIN-YOUAKIM, JJ., Concur. 

Opinion subject to revision prior to official publication.

1 Christian B. Koeppen is now deceased. 

2 The agreement was also not signed by the Kozminskis' former 

counsel, who represented them at the time of the mediation, or the 

mediator.
11 TH C OURT OF A PPEALS

E ASTLAND

, T EXAS

J UDGMENT

Harold Wayne Mitchell, * From the 238th District Court

Of Midland County,

Trial Court No. CR43869

.

Vs. No. 11

- 15

- 00065

- CR * April 2 3 , 2015

The State of Texas, * Per Curiam Memorandum Opinion

(Panel consists of: Wright, C.J.,

Willson, J., and Bailey, J.)

This court has inspected the record in this cause and concludes that the appeal

should be dismissed for want of jurisdiction . Therefore, in accordance with this

court ’ s opinion, the appe al is dismissed.
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

May 7, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-7212

United Scope LLC: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/Notice_of_Product_Exclusions

_05.09.19.pdf. 

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Joseph Barloon

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

May 29, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-3325

ECM Industries LLC: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at 

https://ustr.gov/sites/default/files/enforcement/301Investigations/Notice_of_Product_Exclusions

_5-30-2019.pdf.

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border 

Protection will issue additional instructions on entry guidance and implementation

Sincerely,

Joseph Barloon

General Counsel
[Federal Register Volume 60, Number 9 (Friday, January 13, 1995)]
[Notices]
[Page 3249]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-886]



[[Page 3249]]


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Technical Advisory Committee for Diabetes Translation and 
Community Control Programs; Meeting

    In accordance wtih section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Technical Advisory Committee for Diabetes Translation and 
Community Control Programs.
    Time and Date: 8:30 a.m.-4:30 p.m., Monday, January 30, 1995.
    Place: Rhodes Building, 4th Floor Conference Room, 3005 
Chamblee-Tucker Road, Atlanta, Georgia 30341, telephone 404/488-
5000. (Exit Chamblee-Tucker Road off I-85).
    Status: Open to the public, limited only by the space available.
    Purpose: This committee is charged with advising the Director, 
CDC, regarding priorities and feasible goals for translation 
activities and community control programs designed to reduce risk 
factors, morbidity, and mortality from diabetes and its 
complications. The committee advises regarding policies, strategies, 
goals and objectives, and priorities; identifies research advances 
and technologies ready for translation into widespread community 
practice; recommends public health strategies to be implemented 
through community interventions; advises on operational research and 
outcome evaluation methodologies; identifies research issues for 
further clinical investigation; and advises regarding the 
coordination of programs with Federal, voluntary, and private 
resources involved in the provisions of services to people with 
diabetes.
    Matters to be Discussed: Committee members will discuss CDC's 
role in primary prevention, the National Diabetes Education Program, 
screening issues, the Regenstreif Conference, Policy and economic 
activities, and the status of the Diabetes Control Programs and 
health communication.
    Agenda items are subject to change as priorities dictate.
    Contact Person For More Information: Cheryl Shaw, Program 
Specialist, Division of Diabetes Translation, National Center for 
Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford 
Highway, NE, (K-10), Atlanta, Georgia 30341-3724, telephone 404/488-
5004.

    Dated: January 9, 1995.
William H. Gimson,
Acting Associate Director for Policy Coordination, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 95-886 Filed 1-12-95; 8:45 am]
BILLING CODE 4163-18-M
EXHIBIT 31.1

        CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
               SECTION 302 OF THE SARBANES-OXLEY ACT
        ----------------------------------------------------

     I, Dr. Anchana Chayawatana, hereby certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Lam Liang
Corp.

2. Based on my knowledge, this quarterly report does not contain any
untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect
to the period covered by this quarterly report.

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all
material respects our financial condition, results of operations and
cash flows as of, and for, the periods presented in this quarterly report.

4. The other certifying officers and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) and we have:

(a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to Lam Liang Corp.,
including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report
is being prepared;

(b) Evaluated the effectiveness of our disclosure controls and procedures
and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period
covered by this report based on such evaluation; and

(c) Disclosed in this report any change in our internal control over
financial reporting that occurred during our most recent fiscal quarter
(fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, our internal control
over financial reporting; and

(5) Lam Liang Corp.'s other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over financial
reporting, to our auditors and the audit committee of our board of directors
(or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect our ability to record, process, summarize and
report financial information; and

(b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in our internal control over
financial reporting.

                                   Lam Liang Corp., Registrant

Dated: September 11, 2005            /s/ Anchana Chayawatana
                                   -------------------------------------
                                   By: Dr. Anchana Chayawatana, Chief
                                   Executive Officer, President and
                                   Chairman of the Board of Directors
#### Randy G. SPENCER, Appellant, v. STATE of Missouri, Respondent.

No. WD 51614.

Missouri Court of Appeals, Western District.

June 18, 1996.

*54Rose M. Wibbenmeuyer, Asst. Public Defender, Columbia, for Appellant.

Jeremiah W. (Jay) Nixon, Atty. Gen., Joanne E. Joiner, Asst. Atty. Gen., John Munson Morris, Jefferson City, for Respondent.

Before LOWENSTEIN, P.J., and HANNA and SPINDEN, JJ.

*ORDER*

PER CURIAM.

The Movant’s amended motion for post-conviction relief under Rule 24.035 was denied after evidentiary hearing. Judgment affirmed. Rule 84.16(b).
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

April 12, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-6466

Apex Sourcing & Manufacturing: 

I am pleased to notify you that the United States Trade Representative has determined to 

grant the above-referenced exclusion request submitted pursuant to the notice published at 83 FR 

32181 (‘July 11 notice’). The exclusion determination is set out in a formal notice which has 

been submitted to Office of the Federal Register for publication (‘the exclusion notice’). A prepublication version of the exclusion notice has been posted on the USTR website, at

https://ustr.gov/sites/default/files/enforcement/301Investigations/Notice_of_Product_Exclusions

_04.15.19.pdf.

The scope of the exclusion is governed by the formal HTSUS language in the annex to 

the product exclusion notice, and not by the product descriptions set out in any particular request 

for exclusion. An exclusion in response to your request has been granted by excluding from the 

additional tariffs products covered by a specially drafted description contained in the annex to 

the product exclusion notice. 

In accordance with the July 11 notice, the exclusion applies as of the July 6, 2018 

effective date of the tariff action, and will extend for one year after the exclusion notice is 

published in the Federal Register. As stated in the exclusion notice, U.S. Customs and Border

Protection will issue additional instructions on entry guidance and implementation.

Sincerely,

Stephen P. Vaughn

General Counsel
Exhibit
      32.2





CERTIFICATION
      PURSUANT TO


18
      U.S.C.
      SECTION 1350,


AS
      ADOPTED PURSUANT TO


SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002





In
      connection with the Annual Report of American Tax Credit Trust, a Delaware
      statutory business trust Series I (the “Registrant”) on Form 10-K for the year
      ended March 30, 2008 as filed with the Securities and Exchange Commission on
      the
      date hereof (the “Report”), I, Neal Ludeke, Chief Financial Officer of Richman
      American Credit Corp., manager of the Registrant, certify, pursuant to 18 U.S.C.
      Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
      of
      2002, that:





(1)
            The
                Report fully complies with the requirements of section 13(a) or 15(d)
                of
                the Securities Exchange Act of 1934;
                and




(2)
            The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Registrant.




/s/
                Neal LudekeNeal
                LudekeChief
                Financial Officer of Richman AmericanCredit
                Corp., Manager of the RegistrantJuly
                10, 2008
[Federal Register Volume 60, Number 67 (Friday, April 7, 1995)]
[Notices]
[Page 17827]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-8562]



-----------------------------------------------------------------------


NATIONAL SCIENCE FOUNDATION

Special Emphasis Panel in Information Robotics and Intelligent 
Systems; Notice of Meeting

    In accordance with the Federal Advisory Committee Act (Pub. L. 92-
463, as amended), the National Science Foundation announces the 
following meeting.

    Name: Special Emphasis Panel in Information Robotics and 
Intelligent Systems (1200).
    Date and Time: April 24-25, 1995, 8:30 a.m. to 5:00 p.m.
    Place: Holiday Inn-Arlington Hotel, 4610 N. Fairfax Drive, 
Arlington, VA 22202.
    Type of Meeting: Closed.
    Contact Person: Dr. Howard Moraff, Acting Deputy Division 
Director, Robotics and Intelligence, Room 1115, National Science 
Foundation, 4201 Wilson Blvd., Arlington, VA 22230. Telephone: (703) 
306-1928.
    Purpose of Meeting: To provide advice and recommendations 
concerning proposals submitted to NSF for financial support.
    Agenda: To review and evaluate Robotics and Machine Intelligence 
proposals as part of the selection process for awards.
    Reason for Closing: The proposals being reviewed include 
information of a proprietary or confidential nature, including 
technical information; financial data, such as salaries; and 
personal information concerning individuals associated with the 
proposals. These matters are exempt under 5 U.S.C. 552b(c), (4) and 
(6) of the Government in the Sunshine Act.

    Dated: April 3, 1995.
M. Rebecca Winkler,
Committee Management Officer.
[FR Doc. 95-8562 Filed 4-6-95; 8:45 am]
BILLING CODE 7555-01-M
Exhibit 8

                     List of Subsidiaries of the Registrant
                     --------------------------------------

         The table below lists the Registrant subsidiaries. Unless otherwise
indicated, the Registrant, or one of its subsidiaries, own 100% of the
outstanding capital stock of the subsidiary.

        Name of Subsidiary                             Country of Incorporation
        ------------------                             ------------------------
        Senstar-Stellar Corporation                    Canada
        Magal Senstar Inc.                             United States (Delaware)
        Senstar GmbH                                   Germany
        Kobb Inc.                                      United States (Delaware)
        Magal B.V.                                     The Netherlands
        Senstar-Stellar Latin America S.A. de C.V.     Mexico
        Senstar-Stellar Limited                        United Kingdom
        Smart Interactive Systems, Inc.                United States (Delaware)
        E.S.E. Ltd.                                    Israel
        Magal Security Sisteme S.R.L                   Romania
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

February 7, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-5923

Camco Manufacturing, Inc:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request failed to show that the imposition of additional duties on 

the particular product would cause severe economic harm to you or other U.S. interests. 

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product 

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Stephen P. Vaughn

General Counsel
EXECUTIVE OFFICE OF THE PRESIDENT

OFFICE OF THE UNITED STATES TRADE REPRESENTATIVE

WASHINGTON, D.C. 20508

July 23, 2019

RE: Product Exclusion Request Number: USTR-2018-0025-2377

Quest Technologies dba Crystal Quest:

The purpose of this letter is to inform you that the product exclusion request referenced 

above has been denied. As you are aware, USTR published a Federal Register notice (83 FR 

28710) on June 20, 2018, that announced the Trade Representative’s determination to impose an 

additional duty of 25 percent on certain products from China. On July 11, 2018, the Trade 

Representative published a Federal Register notice (83 FR 32181) which announced that a 

process had been established under which interested persons could request that products falling 

within a covered HTSUS subheading be excluded from the additional duties announced on June 

20.

Your request was reviewed in accordance with the factors and procedures set forth in 

Section B(1) of the July 11 notice. Based on that review, and after careful consideration, your 

request was denied because the request did not contain a sufficient product identification or was 

determined to be non-administrable.

Because USTR will grant exclusion requests on a product specific basis, you may still 

benefit from a product exclusion if a similar product is granted an exclusion. Products for which 

an exclusion has been granted will be periodically announced on the USTR website. Product

exclusions will become legally effective once published in the Federal Register. 

Sincerely,

Joseph Barloon

General Counsel